• Home
  • Dry AMD
  • Our Science
  • Our Team
  • Our Partners
  • News
  • Contact Us
Skip to content
Skip to content
logo
  • Home
  • Dry AMD
  • Our Science
  • Our Team
  • Our Partners
  • News
  • Contact Us

Social

  • Home
  • Social
Strategy

Cambridge startup aims at age-related eye disease with gene therapy

June 24, 2024 Cirrus No comments yet

A Cambridge-based therapeutics company is working on a gene therapy aimed at a key protein in the eye that it says will help older adults against macular degeneration

Strategy

Boosting Key Protein in Eye Cells Shows Promise in preventing AMD

June 7, 2024 Cirrus No comments yet

Increasing the levels of a key protein in eye cells may help protect against age-related macular degeneration (AMD), according to new research led by the University of Bristol.

Search

Categories

  • Strategy (13)

Recent posts

  • Cirrus Therapeutics Strengthens Its Position as a Next-Generation Global Ocular Immunology Leader with Singapore Eye Research Institute (SERI) Collaboration and Additional Financing
  • Cirrus Therapeutics Announces Strategic Expansion to Singapore and Other Key Updates Supporting its Growth as a Leading Global Ocular Immunology Company
  • Q&A: A Blavatnik Fellow’s Journey: Ying Kai Chan on Vision Science, Innovation, and Cirrus Therapeutics

Tags

Agenda Community Equality Initiative Social Strength

© 2025-2026 Cirrus Therapeutics. All rights reserved.

  • Privacy Policy
  • Terms of Service